Pathophysiology, management and treatment of smoke inhalation injury

Sebastian Rehberg, Marc O. Maybauer, Perenlei Enkhbaatar, Dirk M. Maybauer, Yusuke Yamamoto, Daniel L. Traber

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Smoke inhalation injury continues to increase morbidity and mortality in burn patients in both the third world and industrialized countries. The lack of uniform criteria for the diagnosis and definition of smoke inhalation injury contributes to the fact that, despite extensive research, mortality rates have changed little in recent decades. The formation of reactive oxygen and nitrogen species, as well as the procoagulant and antifibrinolytic imbalance of alveolar homeostasis, all play a central role in the pathogenesis of smoke inhalation injury. Further hallmarks include massive airway obstruction owing to cast formation, bronchospasm, the increase in bronchial circulation and transvascular fluid flux. Therefore, anticoagulants, antioxidants and bronchodilators, especially when administered as an aerosol, represent the most promising treatment strategies. The purpose of this review article is to provide an overview of the pathophysiological changes, management and treatment options of smoke inhalation injury based on the current literature.

Original languageEnglish (US)
Pages (from-to)283-297
Number of pages15
JournalExpert Review of Respiratory Medicine
Volume3
Issue number3
DOIs
StatePublished - 2009

Fingerprint

Smoke Inhalation Injury
Reactive Nitrogen Species
Bronchial Spasm
Antifibrinolytic Agents
Mortality
Bronchodilator Agents
Airway Obstruction
Therapeutics
Aerosols
Developed Countries
Anticoagulants
Developing Countries
Reactive Oxygen Species
Homeostasis
Antioxidants
Morbidity
Research

Keywords

  • β -agonists
  • Acute lung injury
  • Anticoagulants
  • Antioxidants
  • Carbon monoxide
  • Cyanide
  • Nitric oxide
  • Reactive oxygen species

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Immunology and Allergy
  • Public Health, Environmental and Occupational Health

Cite this

Rehberg, S., Maybauer, M. O., Enkhbaatar, P., Maybauer, D. M., Yamamoto, Y., & Traber, D. L. (2009). Pathophysiology, management and treatment of smoke inhalation injury. Expert Review of Respiratory Medicine, 3(3), 283-297. https://doi.org/10.1586/ers.09.21

Pathophysiology, management and treatment of smoke inhalation injury. / Rehberg, Sebastian; Maybauer, Marc O.; Enkhbaatar, Perenlei; Maybauer, Dirk M.; Yamamoto, Yusuke; Traber, Daniel L.

In: Expert Review of Respiratory Medicine, Vol. 3, No. 3, 2009, p. 283-297.

Research output: Contribution to journalArticle

Rehberg, S, Maybauer, MO, Enkhbaatar, P, Maybauer, DM, Yamamoto, Y & Traber, DL 2009, 'Pathophysiology, management and treatment of smoke inhalation injury', Expert Review of Respiratory Medicine, vol. 3, no. 3, pp. 283-297. https://doi.org/10.1586/ers.09.21
Rehberg, Sebastian ; Maybauer, Marc O. ; Enkhbaatar, Perenlei ; Maybauer, Dirk M. ; Yamamoto, Yusuke ; Traber, Daniel L. / Pathophysiology, management and treatment of smoke inhalation injury. In: Expert Review of Respiratory Medicine. 2009 ; Vol. 3, No. 3. pp. 283-297.
@article{3450cae36c20438b88af62005ddd4601,
title = "Pathophysiology, management and treatment of smoke inhalation injury",
abstract = "Smoke inhalation injury continues to increase morbidity and mortality in burn patients in both the third world and industrialized countries. The lack of uniform criteria for the diagnosis and definition of smoke inhalation injury contributes to the fact that, despite extensive research, mortality rates have changed little in recent decades. The formation of reactive oxygen and nitrogen species, as well as the procoagulant and antifibrinolytic imbalance of alveolar homeostasis, all play a central role in the pathogenesis of smoke inhalation injury. Further hallmarks include massive airway obstruction owing to cast formation, bronchospasm, the increase in bronchial circulation and transvascular fluid flux. Therefore, anticoagulants, antioxidants and bronchodilators, especially when administered as an aerosol, represent the most promising treatment strategies. The purpose of this review article is to provide an overview of the pathophysiological changes, management and treatment options of smoke inhalation injury based on the current literature.",
keywords = "β -agonists, Acute lung injury, Anticoagulants, Antioxidants, Carbon monoxide, Cyanide, Nitric oxide, Reactive oxygen species",
author = "Sebastian Rehberg and Maybauer, {Marc O.} and Perenlei Enkhbaatar and Maybauer, {Dirk M.} and Yusuke Yamamoto and Traber, {Daniel L.}",
year = "2009",
doi = "10.1586/ers.09.21",
language = "English (US)",
volume = "3",
pages = "283--297",
journal = "Expert Review of Respiratory Medicine",
issn = "1747-6348",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Pathophysiology, management and treatment of smoke inhalation injury

AU - Rehberg, Sebastian

AU - Maybauer, Marc O.

AU - Enkhbaatar, Perenlei

AU - Maybauer, Dirk M.

AU - Yamamoto, Yusuke

AU - Traber, Daniel L.

PY - 2009

Y1 - 2009

N2 - Smoke inhalation injury continues to increase morbidity and mortality in burn patients in both the third world and industrialized countries. The lack of uniform criteria for the diagnosis and definition of smoke inhalation injury contributes to the fact that, despite extensive research, mortality rates have changed little in recent decades. The formation of reactive oxygen and nitrogen species, as well as the procoagulant and antifibrinolytic imbalance of alveolar homeostasis, all play a central role in the pathogenesis of smoke inhalation injury. Further hallmarks include massive airway obstruction owing to cast formation, bronchospasm, the increase in bronchial circulation and transvascular fluid flux. Therefore, anticoagulants, antioxidants and bronchodilators, especially when administered as an aerosol, represent the most promising treatment strategies. The purpose of this review article is to provide an overview of the pathophysiological changes, management and treatment options of smoke inhalation injury based on the current literature.

AB - Smoke inhalation injury continues to increase morbidity and mortality in burn patients in both the third world and industrialized countries. The lack of uniform criteria for the diagnosis and definition of smoke inhalation injury contributes to the fact that, despite extensive research, mortality rates have changed little in recent decades. The formation of reactive oxygen and nitrogen species, as well as the procoagulant and antifibrinolytic imbalance of alveolar homeostasis, all play a central role in the pathogenesis of smoke inhalation injury. Further hallmarks include massive airway obstruction owing to cast formation, bronchospasm, the increase in bronchial circulation and transvascular fluid flux. Therefore, anticoagulants, antioxidants and bronchodilators, especially when administered as an aerosol, represent the most promising treatment strategies. The purpose of this review article is to provide an overview of the pathophysiological changes, management and treatment options of smoke inhalation injury based on the current literature.

KW - β -agonists

KW - Acute lung injury

KW - Anticoagulants

KW - Antioxidants

KW - Carbon monoxide

KW - Cyanide

KW - Nitric oxide

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=70049096501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70049096501&partnerID=8YFLogxK

U2 - 10.1586/ers.09.21

DO - 10.1586/ers.09.21

M3 - Article

AN - SCOPUS:70049096501

VL - 3

SP - 283

EP - 297

JO - Expert Review of Respiratory Medicine

JF - Expert Review of Respiratory Medicine

SN - 1747-6348

IS - 3

ER -